Adenosine A2-receptor activation inhibits neutrophil-mediated injury to coronary endothelium

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 271, Issue 4 40-4, 1996, Pages

  Zhao, Zhi Qing ^a   Sato, Hiroki ^a   Williams, Mark W ^a   Fernandez, Adolfo Z ^a   Vinten Johansen, Jakob ^a,b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

A2 receptor agonist; neutrophil adherence; oxygen free radical; superoxide anion

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 8 (2 NOR 1 ADAMANTYL) 1,3 DIPROPYLXANTHINE; 8 (4 SULFOPHENYL)THEOPHYLLINE; ACETYLCHOLINE; ADENOSINE; ADENOSINE A2 RECEPTOR; CYTOCHROME C; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LEUKOTRIENE B4; OXYGEN RADICAL; SUPEROXIDE; THROMBOCYTE ACTIVATING FACTOR; ADENOSINE RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; CELL ADHESION; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DOG; HEART MUSCLE ISCHEMIA; HEART PROTECTION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; ANIMAL; ARTERY; CORONARY BLOOD VESSEL; DRUG EFFECT; FEMALE; IN VITRO STUDY; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

ADENOSINE; ANIMALS; ARTERIES; CELL ADHESION; CORONARY VESSELS; DOGS; ENDOTHELIUM, VASCULAR; FEMALE; MALE; NEUTROPHILS; RECEPTORS, PURINERGIC P1; SUPEROXIDES; VASOCONSTRICTION; VASODILATION;

EID: 33750830003     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.271.4.h1456     Document Type: Article

References (37)

1. Babbitt, D. G., R. Virmani, and M. B. Forman. Intracoronary adenosine administered after reperfusion limits vascular injury after prolonged ischemia in the canine model. Circulation 80: 1388-1399, 1989.
2. Colli, S., and E. Tremoli. Multiple effects of dipyridamole on neutrophils and mononuclear leukocytes: adenosine-dependent and adenosine-independent mechanisms. J. Lab. Clin. Med. 118: 136-145, 1991.
3. αs-linked receptors uncouples chemoattractant receptors from their stimulus-transduction mechanisms in the neutrophil. Blood 80: 1052-1057, 1992.
4. Cronstein, B. N., R. I. Levin, J. Belanoff, G. Weissmann, and R. Hirschhorn. Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J. Clin. Invest. 78: 760-770, 1986.
5. 2 receptors. J. Immunol. 148: 2201-2206, 1992.
6. 2 receptor on human neutrophils. J. Immunol. 135: 1366-1371, 1985.
7. 2-receptor mechanism (Abstract). FASEB J. 1996.
8. Forman, M. B., C. E. Velasco, and E. K. Jackson. Adenosine attenuates reperfusion injury following regional myocardial ischaemia. Cardiovasc. Res. 27: 9-17, 1993.
9. Gunther, G. R., and M. B. Herring. Inhibition of neutrophil superoxide production by adenosine released from vascular endothelial cells. Ann. Vasc. Surg. 5: 325-330, 1991.
10. Hudspeth, D. A., K. Nakanishi, J. Vinten-Johansen, Z.-Q. Zhao, D. S. McGee, M. W. Williams, and J. W. Hammon, Jr. Adenosine in blood cardioplegia prevents postischemic dysfunction in ischemically injured hearts. Ann. Thorac. Surg. 58: 1637-1644, 1994.
11. Hudspeth, D. A., M. W. Williams, Z.-Q. Zhao, H. Sato, K. Nakanishi, D. S. McGee, J. W. Hammon, J. Vinten-Johansen, and D. G. L. Van Wylen. Pentostatin-augmented interstitial adenosine prevents postcardioplegia injury in damaged hearts. Ann. Thorac. Surg. 58: 719-727, 1994.
12. Jurgensen, C. H., B. E. Huber, T. P. Zimmerman, and G. Wolberg. 3-Deazaadenosine inhibits leukocyte adhesion and ICAM-1 biosynthesis in tumor necrosis factor-stimulated human endothelial cells. J. Immunol. 144: 653-661, 1990.
13. Lefer, D. J., K. Nakanishi, W. E. Johnston, and J. Vinten-Johansen. Antineutrophil and myocardial protection actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation 88: 2337-2350, 1993.
14. Lefer, D. J., K. Nakanishi, and J. Vinten-Johansen. Endothelial and myocardial cell protection by a cysteine-containing nitric oxide donor after myocardial ischemia and reperfusion. J. Cardiovasc. Pharmacol. 22: S34-S43, 1993.
15. Lewis, M., R. Whatley, P. Cain, T. McIntyre, S. Prescott, and G. A. Zimmerman. Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion. J. Clin. Invest. 82: 2045-2055, 1988.
16. Lorant, D. E., K. D. Patel, T. M. McIntyre, R. P. McEver, S. M. Prescott, and G. A. Zimmerman. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils. J. Cell Biol. 115: 223-234, 1991.
17. Ma, X., A. S. Weyrich, D. J. Lefer, and A. M. Lefer. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ. Res. 72: 403-412, 1993.
18. Marone, G., L. Thomas, and L. M. Lichtenstein. The role of agonists that activate adenylate cyclase in the control cAMP metabolism and enzyme release by human polymorphoneuclear leukocytes. J. Immunol. 125: 2277-2283, 1980.
19. Mehta, J. L., D. L. Lawson, F. A. Nicolini, M. H. Ross, and D. W. Player. Effects of activated polymorphonuclear leukocytes on vascular smooth muscle tone. Am. J. Physiol. 261 (Heart Circ. Physiol. 30): H327-H334, 1991.
20. Mullane, K. M. Myocardial ischemia-reperfusion injury: role of neutrophils and neutrophil-derived mediators. In: Human Inflammatory Disease: Clinical Immunology, edited by G. Marone, L. Lichtestein, M. Condorelly, and A. S. Fauci. Toronto, Canada: Dekker, 1988, p. 143.
21. Nakanishi, K., J. Vinten-Johansen, D. J. Lefer, W. C. Fowler III, D. S. McGee, and W. E. Johnston. Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H1650-H1658, 1992.
22. Nees, S., V. Herzog, B. F. Becker, M. Bock, C. Des Rosiers, and E. Gerlach. The coronary endothelium: a highly active metabolic barrier for adenosine. Basic Res. Cardiol. 80: 515-529, 1985.
23. Nichols, W. W., J. L. Mehta, W. H. Donnelly, D. Lawson, L. Thompson, and M. ter Riet. Reduction in coronary vasodilator reserve following coronary occlusion and reperfusion in anesthetized dog: role of endothelium-derived relaxing factor, myocardial neutrophil infiltration and prostaglandins. J. Mol. Cell. Cardiol. 20: 943-954, 1988.
24. Nishida, Y., Z. Honda, and T. Miyamoto. Suppression of human polymorphonuclear leukocyte phagocytosis by adenosine analogs. Inflammation 11: 365-369, 1987.
25. 2 receptor. Naunyn-Schmiedeberg's Arch. Pharmacol. 346: 234-237, 1992.
26. Ohlstein, E. H., and A. J. Nichols. Rabbit polymorphonuclear neutrophils elicit endothelium-dependent contraction in vascular smooth muscle. Circ. Res. 65: 917-924, 1989.
27. Olafsson, B., M. B. Forman, D. W. Puett, A. Pou, C. U. Cates, G. C. Friesinger, and R. Virmani. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon. Circulation 76: 1135-1145, 1987.
28. Pitarys, C. J., R. Virmani, H. D. Vildibill, Jr., E. K. Jackson, and M. B. Forman. Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period. Circulation 83: 237-247, 1991.
29. Stickle, J. E., D. Kwan, and C. W. Smith. Neutrophil function in the dog: shape change and response to a synthetic tripeptide. Am. J. Vet. Res. 46: 225-228, 1985.
30. Tan, P., H. S. Klopfenstein, and J. Vinten-Johansen. Interactive software for analysis of global or segmental cardiac systolic and diastolic performance by pressure-volume (dimension) relations (Abstract). J. Am. Coll. Cardiol. 21: 15A, 1993.
31. Toombs, C. F., D. S. McGee, W. E. Johnston, and J. Vinten-Johansen. Myocardial protective effects of adenosine. Infarct size reduction with pretreatment and continued receptor stimulation during ischemia. Circulation 86: 986-994, 1992.
32. Toombs, C. F., D. S. McGee, W. E. Johnston, and J. Vinten-Johansen. Protection from ischaemic-reperfusion injury with adenosine pretreatment is reversed by inhibition of ATP-sensitive potassium channels. Cardiovasc. Res. 27. 623-629, 1993.
33. Van Wylen, D. G. L., J. Willis, J. Sodhi, R. J. Weiss, R. D. Lasley, and R. M. Mentzer, Jr. Cardiac microdialysis to estimate interstitial adenosine and coronary blood flow. Am J. Physiol. 258 (Heart Circ. Physiol. 27): H1642-H1649, 1990.
34. Williams, M. W., J. E. Jordan, A. Z. Fernandez, Z.-Q. Zhao, and J. Vinten-Johansen. Adenosine (ADO) inhibits unactivated neutrophil (PMN) adherence to thrombin stimulated coronary vascular endothelium (EC) by a P-selectin mechanism (Abstract). FASEB J. 1996.
35. 2 receptors, adenosine inhibits the upregulation of Mac-1 (CD11b/CD18) expression on FMLP-stimulated neutrophils. Am. J. Respir. Cell. Mol. Biol. 9: 179-185, 1993.
36. Zhao, Z.-Q., D. S. McGee, K. Nakanishi, C. F. Toombs, W. E. Johnston, M. S. Ashar, and J. Vinten-Johansen. Receptor-mediated cardioprotective effects of endogenous adenosine are exerted primarily during reperfusion after coronary occlusion in the rabbit. Circulation 88: 709-719, 1993.
37. 1-receptor mediated myocardial infarct size reduction by endogenous adenosine is exerted primarily during ischemia. Cardiovasc. Res. 28: 270-279, 1993.